PRRT2 and myocardial ischemia: IPC can activate protein kinase C (PKC) to open mitochondrial ATP-dependent potassium channels (mitoKATP channels), thereby shortening the duration of action potentials, decreasing ATP consumption, myocardial enzyme leakage, and damage caused by free radicals, and ultimately decreasing myocardial ischemia–reperfusion injury [33].